| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
|
Eur Cytokine Netw
|
2006
|
7.19
|
|
2
|
Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
|
Liver Int
|
2009
|
3.12
|
|
3
|
HIV and coronary heart disease: time for a better understanding.
|
J Am Coll Cardiol
|
2013
|
2.78
|
|
4
|
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
|
J Clin Invest
|
2012
|
2.62
|
|
5
|
Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy.
|
J Clin Endocrinol Metab
|
2008
|
2.53
|
|
6
|
Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.
|
J Clin Endocrinol Metab
|
2002
|
1.98
|
|
7
|
Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.
|
Biochem Biophys Res Commun
|
2003
|
1.79
|
|
8
|
Perilipin deficiency and autosomal dominant partial lipodystrophy.
|
N Engl J Med
|
2011
|
1.61
|
|
9
|
Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance.
|
Lancet
|
2002
|
1.59
|
|
10
|
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.
|
Clin Infect Dis
|
2002
|
1.57
|
|
11
|
[Pleural effusion as a first sign of Ig D lambda multiple myeloma].
|
Ann Med Interne (Paris)
|
2003
|
1.55
|
|
12
|
Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation.
|
AIDS
|
2003
|
1.40
|
|
13
|
Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.
|
Int J Biochem Cell Biol
|
2011
|
1.36
|
|
14
|
PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.
|
Am J Hum Genet
|
2013
|
1.33
|
|
15
|
Seipin deficiency alters fatty acid Delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy.
|
Biochimie
|
2009
|
1.29
|
|
16
|
Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
|
AIDS
|
2003
|
1.29
|
|
17
|
High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors.
|
AIDS
|
2011
|
1.28
|
|
18
|
Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
|
Exp Cell Res
|
2003
|
1.27
|
|
19
|
New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
|
J Clin Endocrinol Metab
|
2007
|
1.27
|
|
20
|
Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients.
|
AIDS Res Hum Retroviruses
|
2006
|
1.25
|
|
21
|
Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
|
Antivir Ther
|
2007
|
1.24
|
|
22
|
Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.
|
Arthritis Res Ther
|
2013
|
1.22
|
|
23
|
Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions.
|
Antivir Ther
|
2006
|
1.20
|
|
24
|
Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
|
Antivir Ther
|
2012
|
1.19
|
|
25
|
GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression.
|
Exp Cell Res
|
2004
|
1.18
|
|
26
|
Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia.
|
Clin Chem
|
2004
|
1.16
|
|
27
|
Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
|
Antivir Ther
|
2004
|
1.14
|
|
28
|
Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues.
|
Antivir Ther
|
2008
|
1.13
|
|
29
|
Prevalence of mutations in AGPAT2 among human lipodystrophies.
|
Diabetes
|
2003
|
1.11
|
|
30
|
HIV-associated lipodystrophy: from fat injury to premature aging.
|
Trends Mol Med
|
2010
|
1.10
|
|
31
|
Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
|
Hepatology
|
2002
|
1.10
|
|
32
|
Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses.
|
Clin Infect Dis
|
2011
|
1.10
|
|
33
|
Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).
|
Antivir Ther
|
2008
|
1.10
|
|
34
|
Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy.
|
AIDS
|
2013
|
1.07
|
|
35
|
Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
|
Antivir Ther
|
2004
|
1.07
|
|
36
|
Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients.
|
Clin Chem
|
2005
|
1.06
|
|
37
|
Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
|
AIDS
|
2006
|
1.05
|
|
38
|
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
|
Liver Int
|
2009
|
1.03
|
|
39
|
The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro.
|
AIDS
|
2004
|
1.02
|
|
40
|
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.98
|
|
41
|
Premature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statin.
|
Arterioscler Thromb Vasc Biol
|
2010
|
0.96
|
|
42
|
Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro.
|
Antivir Ther
|
2004
|
0.96
|
|
43
|
GSK-3beta reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis.
|
Int J Oncol
|
2005
|
0.95
|
|
44
|
HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo.
|
Biochimie
|
2005
|
0.94
|
|
45
|
Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes.
|
Antivir Ther
|
2007
|
0.94
|
|
46
|
Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency.
|
J Clin Endocrinol Metab
|
2010
|
0.93
|
|
47
|
A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
|
Antivir Ther
|
2007
|
0.93
|
|
48
|
Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility?
|
Exp Cell Res
|
2003
|
0.92
|
|
49
|
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.
|
Antivir Ther
|
2012
|
0.92
|
|
50
|
HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin.
|
Aging Cell
|
2013
|
0.91
|
|
51
|
Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci.
|
Diabetes
|
2002
|
0.91
|
|
52
|
Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
|
J Hepatol
|
2010
|
0.89
|
|
53
|
Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.
|
Antimicrob Agents Chemother
|
2008
|
0.89
|
|
54
|
LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue.
|
Am J Pathol
|
2011
|
0.87
|
|
55
|
CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients.
|
J Acquir Immune Defic Syndr
|
2013
|
0.86
|
|
56
|
From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
|
Curr Opin Infect Dis
|
2012
|
0.86
|
|
57
|
Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes.
|
Antivir Ther
|
2011
|
0.86
|
|
58
|
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
|
Clin Infect Dis
|
2012
|
0.85
|
|
59
|
Type A insulin resistance syndrome revealing a novel lamin A mutation.
|
Diabetes
|
2005
|
0.84
|
|
60
|
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
|
AIDS
|
2015
|
0.83
|
|
61
|
What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.
|
Curr Diab Rep
|
2013
|
0.83
|
|
62
|
Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis.
|
J Appl Physiol (1985)
|
2007
|
0.82
|
|
63
|
Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium.
|
Am J Physiol Gastrointest Liver Physiol
|
2002
|
0.82
|
|
64
|
Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.
|
J Lipid Res
|
2010
|
0.82
|
|
65
|
Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman.
|
J Clin Endocrinol Metab
|
2011
|
0.82
|
|
66
|
A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
|
J Clin Endocrinol Metab
|
2011
|
0.81
|
|
67
|
Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy.
|
Clin Endocrinol (Oxf)
|
2013
|
0.81
|
|
68
|
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
|
PLoS One
|
2013
|
0.81
|
|
69
|
Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort.
|
Ann Rheum Dis
|
2012
|
0.81
|
|
70
|
Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathways.
|
PPAR Res
|
2008
|
0.81
|
|
71
|
PPAR and liver injury in HIV-infected patients.
|
PPAR Res
|
2009
|
0.80
|
|
72
|
Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin.
|
Antivir Ther
|
2014
|
0.80
|
|
73
|
Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations.
|
Curr Pharm Des
|
2010
|
0.80
|
|
74
|
LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations.
|
Biochem Soc Trans
|
2011
|
0.79
|
|
75
|
Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.79
|
|
76
|
Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
|
Antivir Ther
|
2006
|
0.79
|
|
77
|
HIV protease inhibitors activate the adipocyte renin angiotensin system.
|
Antivir Ther
|
2010
|
0.79
|
|
78
|
Efficient adenoviral transduction of 3T3-F442A preadipocytes without affecting adipocyte differentiation.
|
Biochimie
|
2005
|
0.78
|
|
79
|
New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand.
|
J Acquir Immune Defic Syndr
|
2015
|
0.78
|
|
80
|
Emerging clinical issues related to management of multiorgan comorbidities and polypharmacy.
|
Curr Opin HIV AIDS
|
2014
|
0.78
|
|
81
|
From lipodystrophy and insulin resistance to metabolic syndrome: HIV infection, treatment and aging.
|
Curr Opin HIV AIDS
|
2007
|
0.78
|
|
82
|
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
|
AIDS
|
2012
|
0.78
|
|
83
|
A-type lamin-linked lipodystrophies.
|
Novartis Found Symp
|
2005
|
0.77
|
|
84
|
Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation.
|
J Cell Physiol
|
2003
|
0.77
|
|
85
|
Adipocyte dysfunction in response to antiretroviral therapy: clinical, tissue and in-vitro studies.
|
Curr Opin HIV AIDS
|
2007
|
0.77
|
|
86
|
Patterns of proteinuria: urinary sodium dodecyl sulfate electrophoresis versus immunonephelometric protein marker measurement followed by interpretation with the knowledge-based system MDI-LabLink.
|
Clin Chem
|
2004
|
0.76
|
|
87
|
Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia.
|
AIDS
|
2015
|
0.76
|
|
88
|
Hepatic molecular effects of rosiglitazone in human non-alcoholic steatohepatitis suggest long-term pro-inflammatory damage.
|
Hepatol Res
|
2013
|
0.76
|
|
89
|
Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort' - authors' reply.
|
Arthritis Res Ther
|
2014
|
0.75
|
|
90
|
Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?
|
AIDS
|
2006
|
0.75
|
|
91
|
Soluble endoglin levels during normotensive and hypertensive pregnancies.
|
Eur J Obstet Gynecol Reprod Biol
|
2007
|
0.75
|
|
92
|
Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naïve patients from the ANRS COPANA cohort.
|
AIDS
|
2017
|
0.75
|
|
93
|
Metabolic abnormalities in chronic hepatitis C. Introduction.
|
Liver Int
|
2009
|
0.75
|
|
94
|
Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia.
|
Clin Chem Lab Med
|
2004
|
0.75
|
|
95
|
Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients: results of the METAFIB study.
|
AIDS
|
2017
|
0.75
|
|
96
|
Evaluation of kryptor cardiac troponin I immunoassay.
|
Ann Clin Biochem
|
2002
|
0.75
|
|
97
|
Authors' reply.
|
Antivir Ther
|
2013
|
0.75
|
|
98
|
[Leptin, a new therapeutic agent for treatment of diabetes?].
|
Med Sci (Paris)
|
2010
|
0.75
|
|
99
|
Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.
|
AIDS
|
2017
|
0.75
|